The FDA granted clearance for Tandem Diabetes Care's SteadiSet infusion set.
1 report, 1 independent
Updated Aug 26
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
The FDA granted clearance for Tandem Diabetes Care's SteadiSet infusion set.
Who's involved
What this event is mainly aboutKeep exploring
The entities involved
- FDA
-
Tandem Diabetes Care, Inc.
U.S. healthcare company
Related events
- A study protocol involving a company based in Mont-Saint-Guibert was approved by the U.S. FDA.
- Tandem Diabetes Care is awaiting FDA clearance for its tubeless Tandem Mobi system while also expanding pump adoption through new product launches.
- The FDA placed a clinical hold on the IND application for the company Aardvark.
Coverage
Newest first; wire copies grouped- Simply Wall St.Undervalued Small Caps With Insider Buying To Explore In August 2025 As the U.S. market experiences a mixed performance, with the Dow Jones Industrial Average retreating from record highs and major i